Answers are grounded in this paper and cite their sources.
When several liver-directed treatments are feasible, patients and physicians may weigh survival benefit, treatment-related risk, and short-term physical burden differently. We used choice-based conjoint analysis with hierarchical Bayes estimation and preference-share simulations to compare preferences of 69 patients with hepatic malignancies and 40 gastroenterologists in Germany across three scenarios describing early-stage hepatocellular carcinoma (Case 1), an isolated colorectal liver metastasis (Case 2) and metastatic uveal melanoma with diffuse hepatic involvement (Case 3). Lifetime extension was the most important attribute for both groups in all scenarios. Patients assigned greater relative importance to well-being after the intervention in Cases 1 and 2 (25.2% vs 10.9% and 22.3% vs 12.1%, posterior probability of direction [pd] ≥ 99%), whereas gastroenterologists assigned greater importance to tumor-removal probability in Case 1 (24.3% vs 17.2%, pd 95.8%). In Case 2, the simulated ablation share was higher among patients (86.6% vs 71.8%, p < 0.01), with the complementary resection share higher among gastroenterologists. In Case 3, simulated shares did not differ significantly. Whether and in which attributes the two groups differed thus depended on the clinical scenario. Patient priorities should therefore not be inferred from general assumptions but addressed explicitly during shared decision-making.
No takes yet. Share an insight, caveat, or question.
Winkelmann et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: